María Erendira
Calleja Cervantes
Bioinformática
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaInstituto de Investigación Sanitaria de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Molecular Therapy - Methods and Clinical Development, Vol. 25, pp. 137-146